Free tool
FAERS Monitor: Spinraza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209531 or its brand name (Spinraza, Nusinersen Sodium). Reports on generic versions are filed under their own applications.
Reports
7,888
Serious
3,872
49% of reports
Hospitalization
2,401
Death reported
798
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache578
- post lumbar puncture syndrome524
- pyrexia410
- procedural pain386
- pneumonia371
- death339
- vomiting315
- asthenia302
- back pain265
- fatigue253
- scoliosis230
- fall186
- malaise184
- nausea177
- pain164
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2016 | 1 |
| 2017 | 637 |
| 2018 | 1,223 |
| 2019 | 945 |
| 2020 | 800 |
| 2021 | 958 |
| 2022 | 801 |
| 2023 | 729 |
| 2024 | 624 |
| 2025 | 594 |
| 2026 | 576 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,271 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| post lumbar puncture syndromeSignal | 524 | 2709.5 | 2404.2 | 702,601 |
| scoliosisSignal | 230 | 102.8 | 90.3 | 22,229 |
| procedural painSignal | 386 | 37.6 | 34.1 | 13,548 |
| pyrexiaSignal | 410 | 3.2 | 2.9 | 613 |
| pneumoniaSignal | 371 | 3.1 | 2.8 | 519 |
| back painSignal | 265 | 3.0 | 2.7 | 365 |
| headacheSignal | 578 | 2.5 | 2.3 | 514 |
| astheniaSignal | 302 | 2.1 | 1.9 | 186 |
| vomiting | 315 | 1.8 | 1.6 | 111 |
| fall | 186 | 1.5 | 1.3 | 30 |
| malaise | 184 | 1.1 | 1.0 | 2 |
| death | 339 | 1.0 | 0.9 | 1 |
| fatigue | 253 | 0.9 | 0.8 | 5 |
| pain | 164 | 0.7 | 0.6 | 19 |
| nausea | 177 | 0.6 | 0.5 | 50 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.